Cefpodoxime & Potassium Clavulanate Tablets Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 325mg
Reference Brands:
Category:
Antibiotics
The salt combination Cefpodoxime / Clavulanic Acid is used for the treatment of Bacterial Infections, Urinary Tract Infection, Gonorrhea, Pneumonia, Pyelonephritis, Sinusitis and other conditions.
Cefpodoxime & Potassium Clavulanate Tablets is available in Tablets
and strengths such as 325mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Cefpodoxime & Potassium Clavulanate Tablets is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Cefpodoxime & Potassium Clavulanate Tablets can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Cefpodoxime / Clavulanic Acid is used for the treatment, control, prevention, & improvement of the following diseases, conditions and symptoms:
· Bacterial Infections
· Urinary Tract Infection
· Gonorrhea
· Pneumonia
· Pyelonephritis
· Sinusitis
· Infections After Surgery
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing